Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Find out which platform is best for retirement investing to enhance your portfolio. Make informed choices for your financial future.
24,828 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A wave of cheaper AI models is reshaping demand for hardware, boosting NVIDIA, Micron, and SanDisk as investors weigh...
Applied Optoelectronics eyes a major upcycle as AI datacenters drive a sharp revenue forecast. The company predicts 2...
Bitcoin is still in a slowdown phase as traders unwind risk, with CryptoQuant data showing ongoing deleveraging but n...
Bitcoin briefly pierced the $68,000 level on Saturday as global tensions intensified, sending XRP past BNB in market ...
Geopolitical tensions push markets lower as inflation and energy risk linger. This piece analyzes Coca-Cola as a cand...
BigBear.AI released its latest quarterly results after the bell, showing a sharp balance-sheet improvement and a path...
The Bank of Japan unveils a sandbox to test whether central bank reserves can run on blockchain rails, a landmark ste...
Stocks moved sharply in both directions on Tuesday as investors weighed the risk of broader conflict in the Middle Ea...
Duquesne Family Office reveals a sizable XLF position in its Q4 2025 filings, marking one of the boldest bets on fina...
Occidental Petroleum uses $9.7B from the OxyChem sale to trim debt, boosting cash flow and dividends. Berkshire Hatha...
A rising hedge fund led by Leopold Aschenbrenner bets big on power-generation assets and bitcoin miners to back the r...